Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)
Titel:
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)
Auteur:
Lee, Choong-kun Chon, Hong Jae Cheon, Jaekyung Lee, Myung Ah Im, Hyeon-Su Jang, Joung-Soon Kim, Min Hwan Park, Sejung Kang, Beodeul Hong, Moonki Kim, Jin Won Park, Hyung Soon Kang, Myoung Joo Park, Young Nyun Choi, Hye Jin